trimipramine controlled-release once-daily formulation

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug Nametrimipramine controlled-release once-daily formulation
Drug Alias NameNocturel
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnxiety DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZysis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZysis Ltd
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersDepression

Other Information

ATC CodeN/A
Related LinksN/A